SCHEMBL24742858

SCHEMBL24742858

BC1OC(CO)C(OP(C)(=S)S)C1OC

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24742680 0.85 LGALS8 (0.33) LGALS8
SCHEMBL21202664 0.85 — —
SCHEMBL19777495 0.82 LGALS8 (0.33) LGALS8
SCHEMBL8059872 0.80 LGALS8 (0.34) LGALS8
SCHEMBL26029389 0.80 LGALS8 (0.34) LGALS8
SCHEMBL8607210 0.75 LY96 (0.34) LGALS8
SCHEMBL20334736 0.73 — —
SCHEMBL22736772 0.73 FBP1 (0.37) LGALS8
SCHEMBL13447823 0.73 LGALS8 (0.35) LGALS8
SCHEMBL17577490 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4105328-A1 ANTISENSE-OLIGONUCLEOTIDES FOR PREVENTION OF KIDNEY DYSFUNCTION PROMOTED BY ENDOTHELIAL DYSFUNCTION BY EPHRIN-B2 SUPPRESSION Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2022-12-21 — — EP disclosed
Send feedback